Expedited pharma patenting in Brazil.
This article has the purpose of bringing an updated landscape on expedited protection of pharmaceutical patent applications in Brazil. The serious backlog of examination of patent applications in Brazil is a fact well known worldwide for a long time. In 2017, said backlog related to pharmaceutical patent applications achieved a mean time of about 11-13 years. On the other hand, there are alternatives to attempt to surpass such huge delay, based on official regulations for expediting examination, which have shown to be quite effective. Actual examples of pharmaceutical patents beneficiated from such fast track rules have received grant decisions within about 0.5-3.5 years counted from request for accelerated examination.